Company intelligence / Profile preview
Beijing Youfeng Biological Technology Co., Ltd.
Beijing, Chinayoufengbio.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Partnered with Generex Biotechnology for development of Ii-Key SARS-CoV-2 vaccine, including clinical trials in China and exclusive sales rights outside US and certain Latin American countries.[1][3][11]
- Therapeutic areas
- Infectious Diseases
- Modalities
- Peptide vaccine
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
03
Partnerships
Generex Biotechnology CorporationBeijing Youfeng International Consulting Co., Ltd.National Institute for Viral Disease Control and Prevention (Chinese CDC)Beijing Guoxin Haixiang Equity Investment Partnership
Beyond the preview
Go deeper on Beijing Youfeng Biological Technology Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Beijing Youfeng Biological Technology Co., Ltd..